Afrin cold conference
This article was originally published in The Tan Sheet
Executive Summary
Schering-Plough sponsors Feb. 1 "telephonic press briefing" on the Afrin Cold Front Warning System, which suggests that 70 metropolitan areas nationwide are on cold "alert" (meaning approximately 3 in 4 household are affected by viruses that cause colds). The two-person "cold front panel" suggested that cold- sufferers "know [their] symptoms" and treat them with single- indication OTCs, such as Afrin for nasal congestion. PR firm Ruder Finn organized the event
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning